Cheaper generic Ozempic is coming soon — but not for Americans
Summary
“Unfortunately, the U.S. has been much more receptive to efforts to ‘evergreen’ patent life by adding follow-on patents,” said Mark Lemley, a professor at Stanford Law School who teaches intellectual property and patent law.
Read More